Longevity supplements › Taurine and Aging › Studies

Trial, not randomized · measured lab tests or safety

Trial in healthy men and in rats: taurine raised blood vessel repair cell colonies

Katakawa and colleagues · Hypertension research : official journal of the Japanese Society of Hypertension · 2016

Original title: Taurine and magnesium supplementation enhances the function of endothelial progenitor cells through antioxidation in healthy men and spontaneously hypertensive rats.

Under review. A person has not yet checked this summary against the paper. It is written from the PubMed abstract. Until a person checks it, search engines are asked not to list this page.

What the study found

Points to benefit

Taurine increased blood vessel repair cell colonies and lowered free radical levels and TBARS scores in healthy men and in rats. Authors suggest this may prolong lifespan by preventing heart disease.

The study at a glance

Type of study
Trial, not randomized
Who or what was studied
healthy men (number not stated), plus high blood pressure rats
What was tested
3 g of taurine a day (or magnesium 340 mg a day) for 2 weeks in men; taurine in drinking water for 4 weeks in rats
What it measured
Lab tests or markers
Daily amount
3 g a day
How long
2 weeks
Who has a stake
No disclosure in PubMed
No disclosure in PubMed.
Journal
Hypertension research : official journal of the Japanese Society of Hypertension, 2016
Source
PubMed record 27412799. This page is based on the abstract only.

How much this study counts

  • –Not randomized: the groups may differ in ways that affect the result.
  • •The abstract does not say how many people took part.
  • –Short: 2 weeks. Longer-term effects are unknown.
  • –Measured lab tests or markers, which stand in for aging and age-related decline. A better marker does not always mean better health.
  • •The PubMed record has no conflict-of-interest statement.
  • •Summarized from the PubMed abstract only. The full paper may hold details the abstract leaves out.

✓ Strength– Limit• Note

These points come from fixed rules about the type of study, its size and length, what it measured, and who has a stake. Every study on Digestery gets the same rules.

Where this study sits

Each dot is one on-topic paper on this question. Steps near the top answer the question more directly.

↑ Stronger evidence

  1. Trials in people: aging and age-related decline

    1

    1 benefit

  2. Trials in people: other measures

    3

    1 benefit, 1 mixed, 1 no difference

  3. Trials in people: lab tests or safety

    2

    2 benefit

    ↑ This study is the ringed dot
  4. Population studies

    2

    1 no difference, 1 harm

  5. Blood levels and genes

    2

    1 mixed, 1 no direction

  6. Animals

    2

    1 benefit, 1 no difference

  7. Cells in a dish

    1

    1 benefit

↓ Weaker evidence

  • Points to benefit
  • Mixed
  • No difference
  • No direction
  • Points to harm

How it fits with the other research

The short answer to “Does taurine slow aging?”

Not shown in people.

Confidence: very low. Based on 13 on-topic papers.

Read the full answer

Few other papers sit on the same step, so there is little to compare it with.

Other papers on the same step

See all 13 studies on this question

How this page was made

Label

First read of the abstract
Claude Sonnet
Independent second read
Claude Haiku
Differences settled
The reviewer corrected 1 field after reading the abstract. Claude Opus 5.5.
Headline
Claude Sonnet, from the checked study record. A script checked its numbers and wording.
Numbers
Checked against the abstract by a script
“How much this study counts”
Fixed rules, the same for every study
Source check by a person
Not yet. Required before search engines may list this page.

Spot an error? Email a flag with a link to your source, or use the form on the question page.